---
schema_version: "secwatch.filing_event.v1"
accession: "0001801170-21-000020"
form_type: "8-K"
ticker: "CLOV"
cik: "0001801170"
company_name: "CLOVER HEALTH INVESTMENTS, CORP. /DE"
filed_at: "2021-08-16T23:59:59+00:00"
generated_at: "2026-06-29T10:16:58.248583+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Clover Health CFO Joseph Wagner departs; Mark Herbers named interim CFO

## Summary
- Joseph Wagner stepped down as CFO on August 13, 2021; will provide consulting services for 12 months at $10,000 per month.
- Mark Herbers (Director at AlixPartners) appointed interim CFO; company pays $175,000 per month to APS for his services.
- Herbers will serve as principal financial and accounting officer while permanent CFO search is conducted.
- Separation agreement extends post-termination exercise period of Wagner's vested stock options by one year.
- If consulting period is terminated early, company pays Wagner a lump sum equal to remaining monthly fees.

## SEC filing metadata
- accession: 0001801170-21-000020
- form_type: 8-K
- ticker: CLOV
- cik: 0001801170
- company_name: CLOVER HEALTH INVESTMENTS, CORP. /DE
- filed_at: 2021-08-16T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1801170/000180117021000020/0001801170-21-000020-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1801170/000180117021000020/clov-20210813.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001801170-21-000020
- JSON: https://secwatch.observer/filing/0001801170-21-000020.json
- Plain text: https://secwatch.observer/filing/0001801170-21-000020.txt

## Key facts
- Executive change
  Joseph Wagner departed as Chief Financial Officer at CLOVER HEALTH INVESTMENTS, CORP. /DE.
  - Action: stepped down
  - Role: Chief Financial Officer
  source text: On July 15, 2021, Clover Health Investments, Corp. (the “Company”) announced that Joseph Wagner, the Company’s Chief Financial Officer, would be stepping down as an officer of the company on August 13, 2021 (the “Departure Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1801170/000180117021000020/0001801170-21-000020-index.htm
- Executive change
  Mark Herbers was appointed as interim Chief Financial Officer at CLOVER HEALTH INVESTMENTS, CORP. /DE.
  - Action: appointed
  - Role: interim Chief Financial Officer
  source text: On August 13, 2021, the Company’s Board of Directors appointed Mr. Herbers as interim Chief Financial Officer of the Company, to serve as the Company’s principal financial officer and principal accounting officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1801170/000180117021000020/0001801170-21-000020-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.